Mark Schoenberg is Chief Medical Officer at UroGen Pharma Ltd. (URGN). They have made 41 open-market trades across 1 company since 2019, most recently 2026-09-08.
CIK 0001763581
3 open-market purchases totalling $123K since 2019, against 38 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| URGN | 59,882 | $2.1M |
Shares reported on the most recent Form 4, priced at the 2026-09-09 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| URGN | SELL | 2026-09-08 | 2026-09-09 | $42.92 | $37K | -1.5% | -15.9% | — |
| URGN | SELL | 2026-08-20 | 2026-08-24 | $47.05 | $2.9M | -3.9% | -10.8% | — |
| URGN | SELL · 10b5-1 | 2026-07-09 | 2026-07-10 | $40.00 | $400K | +13.0% | +23.9% | -1.0% |
| URGN | SELL · 10b5-1 | 2026-06-22 | 2026-06-24 | $35.01 | $350K | +6.4% | +15.1% | +20.2% |
| URGN | SELL | 2026-06-08 | 2026-06-09 | $27.30 | $143K | +24.1% | +42.5% | +55.2% |
| URGN | SELL · 10b5-1 | 2026-05-08 | 2026-05-11 | $30.00 | $300K | -3.7% | -9.7% | +49.1% |
| URGN | SELL | 2026-02-03 | 2026-02-04 | $19.69 | $145K | +0.1% | -0.5% | +15.8% |
| URGN | SELL · 10b5-1 | 2025-11-19 | 2025-11-20 | $25.00 | $250K | -1.5% | -4.6% | -9.9% |
| URGN | SELL | 2025-09-08 | 2025-09-09 | $19.11 | $17K | -13.4% | -20.8% | +11.3% |
| URGN | SELL | 2025-08-11 | 2025-08-13 | $17.69 | $177K | -6.4% | -5.0% | +19.5% |
| URGN | SELL | 2025-07-28 | 2025-07-30 | $19.14 | $197K | -4.9% | +1.5% | +5.3% |
| URGN | SELL | 2025-06-09 | 2025-06-11 | $7.37 | $38K | +88.1% | +94.3% | +182.3% |
| URGN | SELL | 2025-01-31 | 2025-02-04 | $11.14 | $30K | -4.6% | -9.7% | -3.0% |
| URGN | SELL | 2024-09-09 | 2024-09-12 | $13.08 | $11K | +0.3% | -5.8% | -12.1% |
| URGN | SELL | 2024-06-10 | 2024-06-11 | $13.08 | $135K | +30.4% | +26.0% | -0.4% |
| URGN | SELL | 2024-03-18 | 2024-03-20 | $14.05 | $169K | -5.3% | -7.7% | +13.4% |
| URGN | SELL | 2024-02-01 | 2024-02-05 | $15.78 | $60K | +18.2% | +13.5% | -12.9% |
| URGN | SELL | 2024-01-31 | 2024-02-02 | $15.74 | $60K | +17.9% | +13.0% | -12.5% |
| URGN | SELL | 2023-01-31 | 2023-02-02 | $10.12 | $19K | -12.6% | -5.5% | +19.5% |
| URGN | SELL | 2022-10-31 | 2022-11-02 | $11.85 | $3K | -20.7% | -27.4% | -10.1% |
| URGN | SELL | 2022-08-01 | 2022-08-25 | $7.81 | $2K | -11.4% | -6.8% | -9.4% |
| URGN | SELL | 2022-04-30 | 2022-05-03 | $6.62 | $2K | -11.9% | -18.8% | +10.2% |
| URGN | SELL | 2022-01-31 | 2022-02-02 | $7.58 | $10K | -2.4% | -14.9% | -4.9% |
| URGN | SELL | 2022-01-26 | 2022-01-28 | $8.09 | $898 | +8.9% | -16.8% | +3.7% |
| URGN | BUY | 2021-11-18 | 2021-11-19 | $13.10 | $2K | -1.3% | -21.8% | -46.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.